Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| androgen deprivation prostate therapy |
|
USRF - Androgen Deprivation Treatment. Part I. History 2nd Quarter, 2001 - The prostate gland is an androgen-dependent organ. the Viadur implant---and the continuing interest in androgen-deprivation therapy. NeLM - Androgen deprivation therapy for localised prostate cancer Title, Androgen deprivation therapy for localised prostate cancer increases deprivation therapy (ADT) in the treatment of localised prostate cancer in Hormone Therapy-- What Is That? Androgen Deprivation Therapy for Hormone therapy (also known as "androgen deprivation therapy") for prostate cancer to reduce testosterone is usually achieved in one of three ways: Heart Risk from Prostate Therapy Androgen deprivation therapy may be offered before other treatments for prostate cancer, especially radiation therapy. It may also be offered after other RACGP | Osteoporosis from androgen deprivation therapy in prostate Nicholas McLeod, Chi Can Huynh, Prem Rashid Bone complications from metastatic disease in prostate cancer have been well documented. JAMA -- Androgen Deprivation Therapy for Prostate Cancer, July 13 Context Prostate cancer is the most common nonskin cancer and second most common cause of cancer mortality in US men. Androgen deprivation therapy (ADT), NEJM -- Risk of Fracture after Androgen Deprivation for Prostate Background The use of androgen-deprivation therapy for prostate cancer has increased substantially over the past 15 years. This treatment is associated with Diabetes and Cardiovascular Disease During Androgen Deprivation Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality J Natl Cancer Inst, October 17, 2007; 99(20): 1516 Androgen Deprivation Therapy-induced Fractures in Men With Androgen Deprivation Therapy-induced Fractures in Men With Nonmetastatic Prostate Cancer: What Do We Really Know? Celestia S. Higano, MD Androgen deprivation therapy for prostate cancer may encourage A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely Androgen Deprivation Therapy for Localized Prostate Cancer and the Androgen deprivation therapy (ADT) is increasingly being used in combination with local therapy to treat patients with high-risk localized prostate cancer. Determinants of androgen deprivation therapy use for prostate BACKGROUND: The use of androgen deprivation therapy for prostate cancer has been increasing, even in settings for which there is weak or no evidence of The Effect Of Androgen Deprivation Therapy On Periodontal Disease This study with a small sample size is the first to suggest that men with prostate cancer receiving androgen deprivation therapy exhibit a three-fold higher Research Activities, July 2006: Men's Health: Androgen deprivation Nearly half of all men with prostate cancer receive androgen deprivation therapy at some point in their course of treatment, since prostate cancer growth is Intermittent Androgen Deprivation Therapy for Prostate Cancer Androgen deprivation therapy for prostate cancer is associated with several complications, including loss of libido, hot flashes, night sweats, ACS :: Hormone (Androgen Deprivation) Therapy Detailed Guide: Prostate Cancer. Hormone (Androgen Deprivation) Therapy. Hormone therapy is also called androgen deprivation therapy (ADT) or androgen Androgen Deprivation Therapy Does Not Keep Localized Prostate Oregon Health & Science University Cancer Institute researchers wanted to know if depriving men of testosterone actually keeps cancer from spreading beyond Prostate Cancer and Prostatic Diseases - Abstract of article Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer Androgen deprivation therapy for prostate cancer may increase risk Androgen deprivation therapy â” one of the most common treatments for prostate cancer â” may increase the risk of death from heart disease in patients over |
| androgen deprivation prostate therapy |
|
biopsy effects prostate side abstinence congestion due prostate blog massage prostate spot 2006 awareness cancer month prostate |